drugset / Trial / NCT00969553
Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this trial is to identify the maximum tolerated dose (MTD) of BI 6727 in Asian cancer patients, and to provide safety data in terms of drug-related adverse events.
Timeline
- Start
- 2009-08
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Volasertib | Small molecule | — | Intravenous |